Informace o výskytu podezření na padělku léčivého přípravku Keytruda

The State Institute for Drug Control (ŠÚKL) received information from the European Medicines Agency (EMA) about suspected counterfeit Keytruda 100 mg/vial in batches Z016478 and Z016479 with expiration date 05/2027. Keytruda 100 mg/vial is registered in the Czech Republic as Keytruda 25 mg/ml infusion concentrate in 1x4 ml package. The marketing authorization holder confirmed that these batches were never supplied to the market in the Czech Republic. ŠÚKL urges all operators to provide information immediately if they encounter these batches. Contact is available by phone at +420 272 185 363 or +420 272 185 333, or by email at zavady@sukl.gov.cz or infs@sukl.gov.cz.